Anatomical and Neurochemical Substrates of Drug Reward Determined by the Conditioned Place Preference Technique-Reference-Cited by-同舟云学术

Anatomical and Neurochemical Substrates of Drug Reward Determined by the Conditioned Place Preference Technique

Published:1987 Issue: Volume: Page:275-290
ISSN:
Container-title:Methods of Assessing the Reinforcing Properties of Abused Drugs
language:
Short-container-title:

Author:

Phillips Anthony G.,Fibiger Hans C.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4612-4812-5_15.pdf

Reference56 articles.

1. Andrade, R., & Aghajanian, G. K. (1982). Neurotensin selectively activates dopaminergic neurons of the substantia nigra. Society for Neuroscience Abstracts, 7, 753.

2. Baxter, B. L., Gluckman, I. I., Stein, L., & Scerni, R. A. (1974). Self-injection of apomorphine in the rat: Positive reinforcement by a dopamine receptor stimulant. Pharmacology Biochemistry & Behavior, 2, 387–391.

3. Bozarth, M. A. (1983). Opiate reward mechanisms mapped by intracranial self-administration. In J. E. Smith & J. D. Lane (Eds.), The neurobiology of opiate reward processes (pp. 331–359). Amsterdam: Elsevier.

4. Bozarth, M. A., & Wise, R. A. (1981a). Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sciences, 28, 551–555.

5. Bozarth, M. A., & Wise, R. A. (1981 b). Heroin reward is dependent on a dopaminergic substrate. Life Sciences, 29, 1881–1886.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Dopaminergic Projection System, Basal Forebrain Macrosystems, and Conditioned Stimuli;CNS Spectrums;2008-01

2. Activation of Group II Metabotropic Glutamate Receptors in the Nucleus Accumbens Shell Attenuates Context-Induced Relapse to Heroin Seeking;Neuropsychopharmacology;2005-12-07

3. Drug addiction: Functional neurotoxicity of the brain reward systems;Neurotoxicity Research;2001-01

4. The Role of the Striatopallidal and Extended Amygdala Systems in Drug Addiction;Annals of the New York Academy of Sciences;1999-06

5. Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm;Brain Research;1998-06